PhaseBio Pharmaceuticals, Inc. (PHAS) earnings
Quarterly and annual PHAS reports and results, each read against the price at its own news timestamp. Back to the PHAS overview →
No PHAS earnings events in the measured window.
Nothing matched in the current window — the PHAS overview has every event we measure for this name.
Get an email when PHAS moves on news →Keep exploring
More PHAS: analyst actions → · SEC filings → · PHAS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Checkpoint Therapeutics, Inc. (CKPT) | 389 | 0.00% | 49% |
| Select Medical Holdings Corporation (SEM) | 387 | -0.03% | 41% |
| ARADIGM CORP COMMON STOCK (ARDM) | 384 | 0.00% | 39% |
| HISTOGENICS CORP COMMON (HSGX) | 383 | -0.30% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.